Showing results (1-10 of 1,309) with videos related to
Sort By:
Pageof 131
Medizinische Klinik (Munich, Germany : 1983)|January 15, 2009
[Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?]Janine Pöss, Michael Böhm, Ulrich LaufsDrugs|February 3, 2006
HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and riskUlrich Laufs, Florian Custodis, Michael BöhmClinical Research in Cardiology : Official Journal of the German Cardiac Society|December 25, 2010
Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010Christoph Gensch, Uta Hoppe, Michael Böhm, et al.Atherosclerosis|October 6, 2009
An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterolOliver Weingärtner, Ulrich Laufs, Michael Böhm, et al.BMJ Case Reports|June 21, 2011
Bad gut feeling: ACE inhibitor induced intestinal angioedemaOliver Weingärtner, Nadja Weingärtner, Michael Böhm, et al.Journal of the American College of Cardiology|August 27, 2013
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosisDaniel Urban, Janine Pöss, Michael Böhm, et al.Atherosclerosis|February 2, 2010
Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular riskOliver Weingärtner, Dieter Lütjohann, Michael Böhm, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 17, 2008
Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart AssociationHelge Möllmann, Holger Nef, Michael Böhm, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 25, 2007
Perceived psychosocial stress and cardiovascular risk factors in obese and non-obese patientsKishor Lahiri, Volker Rettig-Ewen, Michael Böhm, et al.The Journal of Biological Chemistry|September 16, 2008
Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinaseBettina Johanna Stuck, Matthias Lenski, Michael Böhm, et al.Pageof 131